Yilin Su

Papers

Total Citations

H-Index

About

Yilin Su is an emerging researcher at the forefront of biomedical nanotechnology, with a particular focus on biologically inspired nanorobotics and drug delivery systems. Su's most notable contribution to date is the pioneering development of enzyme-powered bacterial outer membrane vesicle nanorobots, a groundbreaking advance that addresses one of the field's most persistent challenges: reconciling autonomous therapeutic function with biocompatibility. By leveraging the natural architecture of bacterial outer membrane vesicles rather than conventional inorganic materials, Su's work introduces a new paradigm for precision therapy that preserves rich biological functionality while enabling autonomous navigation and targeted treatment. This innovation has rapidly garnered 43 citations since its 2024 publication, a remarkable reception that signals its transformative potential within the nanomedicine community. Su's research sits at a compelling intersection of microbiology, materials science, and therapeutic engineering, offering solutions with direct implications for cancer treatment and other conditions requiring site-specific drug delivery. For students and researchers exploring the next generation of intelligent therapeutic platforms, Su's work represents an important and exciting frontier worth following closely.